Frovocimab (Anti-PCSK9)

Frovocimab (Anti-PCSK9) is a humanized IgG4 monoclonal antibody that neutralizes proprotein convertase subtilisin-kexin type 9 (PCSK9). MW: 146.88 KD.

Price Not Available 1mg Frovocimab (Anti-PCSK9) Supplier Page
Trivial name LY 3015014
Catalog Number A2876
CAS# 1643672-70-1
Size 1mg